- 期刊
Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
延伸閱讀
- 蕭淑華、吳達仁（2014）。Restriction of Metformin Therapy in Patients with Type 2 Diabetes Mellitus。內科學誌，25(1)，1-6。https://doi.org/10.6314/JIMT.2014.25(1).01
- Chen, Y. J., Hsieh, M. C., Yang, C. C., & Hwu, C. M. (2018). Hypoglycemia-Related Emergency Department Visits in Patients with Type 2 Diabetes Mellitus: Focusing on DPP-IV inhibitor vs. Sulfonylurea Treatment on Top of Metformin. Formosan Journal of Endocrinology and Metabolism, 9(1), 10-17. https://doi.org/10.6856/FJEM.201806_9(1).0002
- Raub, R. M., & Goldberg, S. J. (2012). Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome. Cholesterol, 2012(), 180-184. https://doi.org/10.1155/2012/961410
- Hirao, K., Maeda, H., Shirabe, S. I., Yamamoto, R., Hirao, T., Hirao, S., Yamauchi, M., & Arai, K. (2012). Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA_(1c) Levels in Japanese Patients with Type 2 Diabetes Mellitus. Japanese Clinical Medicine, (), 1-7. https://doi.org/10.4137/JCM.S8571
- Tsai, C. T., Wu, J. L., & Lai, C. H. (2021). Association between Current Metformin Use and Tuberculosis Infection in Patients with Diabetes Mellitus: A Nationwide Population-Based Study. E-Da Medical Journal, 8(1), 1-8. https://doi.org/10.6966/EDMJ.202103_8(1).0001